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Recent discoveries of the glymphatic system and of meningeal lymphatic vessels have
generated a lot of excitement, along with some degree of skepticism. Here, we summarize
the state of the field and point out the gaps of knowledge that should be filled through further
research. We discuss the glymphatic system as a system that allows CNS perfusion by the
cerebrospinal fluid (CSF) and interstitial fluid (ISF). We also describe the recently
characterized meningeal lymphatic vessels and their role in drainage of the brain ISF, CSF,
CNS-derived molecules, and immune cells from the CNS and meninges to the peripheral
(CNS-draining) lymph nodes. We speculate on the relationship between the two systems
and their malfunction that may underlie some neurological diseases. Although much
remains to be investigated, these new discoveries have changed our understanding of
mechanisms underlying CNS immune privilege and CNS drainage. Future studies should
explore the communications between the glymphatic system and meningeal lymphatics in
CNS disorders and develop new therapeutic modalities targeting these systems.
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Perivascular pathways: pseudolymphatic vessels 
of the brain?
In peripheral organs, colloids are extravasated across a fenestrated 
capillary bed, and these proteins, as well as excess tissue fluid, are 
returned to the circulating blood through a dense network of lym-
phatic vessels (1, 2). In the CNS, the blood-brain barrier prevents 
unregulated protein and fluid entry into brain (3, 4); however, solu-
ble waste products are still released into the brain’s interstitial spac-
es as a consequence of its high metabolic rate. The CNS is the only 
organ system of the body lacking classically defined lymphatic ves-
sels and tissues, and as a result has developed unique adaptations 
for waste clearance and fluid balance (5). Choroid plexus epithelial 
cells actively secrete cerebrospinal fluid (CSF) within the cerebral 
ventricles (4, 6–8), ultimately draining into the subarachnoid space 
(SAS) surrounding the brain, which has long been considered to 
act as a sink for interstitial waste (6, 9). How metabolites produced 
and released deep within the brain’s extracellular spaces ultimately 
clear to the subarachnoid CSF compartment remains a persistent 
question (7–9). Early studies of the anatomy of brain waste clear-
ance used tracer molecules to identify pathways of interstitial fluid 
(ISF) and solute drainage from the parenchyma. Injection of Blue 
Dextran 2000 or horseradish peroxidase (HRP) directly into the 
caudate nucleus of rats showed that these interstitial solutes did not 
move through the parenchyma isotropically, but rather drained via 
preferential pathways, specifically the perivascular spaces of cere-
bral blood vessels (10, 11). Molecules of vastly different molecular 
weights, such as albumin (69 kDa) and polyethylene glycols (900 
Da and 4 kDa), all cleared from brain with nearly identical half-
times of disappearance, leading to the conclusion that the efflux of 
ISF and its constituent solutes was by bulk fluid flow and not dif-
fusion (12). Similarly, HRP injected into the CSF of cats was found 
to use these same perivascular conduits to rapidly enter the brain, 
penetrating to the level of capillary basement membranes within 
4 to 10 minutes of injection (13, 14). Consequently, a model was 
advanced in which the brain’s perivascular spaces were assigned 
a pseudolymphatic function, acting as ducts to remove metabolic 
waste products and deliver fresh CSF to the interstitium.
The glymphatic system: anatomy and function 
in health and disease
Observations that ISF and CSF were moving in opposite direc-
tions within this exchange pathway led to the hypothesis that 
there are discrete subsets of perivascular spaces specialized 
for either ISF efflux or CSF influx. In an attempt to identify the 
inflow and clearance arms of this system, Iliff and colleagues 
(15) injected fluorescent tracers into the CSF and striatum of 
Tie2-GFP:NG2-DsRed double reporter mice to visualize all cere-
bral blood vessels based on GFP-expressing endothelial cells 
(ECs) and DsRed-expressing perivascular cells (15). Here they 
observed that CSF-based tracer entered the brain specifically 
within the perivascular spaces of double-positive vessels, indica-
tive of cerebral-penetrating arteries, whereas ISF tracer drained 
from brain exclusively alongside single-positive large caliber 
veins, such as the internal cerebral and caudal rhinal veins (15). 
Additionally, perivascular aquaporin-4 (AQP4) channels, dense-
ly expressed in astrocyte end-foot processes (16), were found to 
play an important role in facilitating flow through this pathway. 
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knockout, CSF volume reduction, or alteration of posture all led 
to increased brain and reduced cervical lymph node lactate lev-
els (21), even in the clearance-promoting anesthetized state (20). 
The importance of glymphatic clearance of interstitial solute is 
perhaps best demonstrated by the fact that its failure contributes 
to the pathophysiology of various CNS diseases. In the aged brain 
and in a murine transgenic model of Alzheimer’s disease, glym-
phatic CSF influx is reduced and the clearance of Aβ is profoundly 
impaired (22, 23). Interestingly, pretreating young wild-type mice 
with Aβ suppressed glymphatic influx, suggesting that not only is 
Aβ aggregation a consequence of a breakdown of flow within this 
pathway, but it may also be an independent cause of glymphatic 
dysfunction (23). Further, glymphatic impairment is a prominent 
feature of cerebrovascular disease, including both subarachnoid 
hemorrhage and multiple microinfarction (24, 25). Following 
traumatic brain injury, reduced clearance of cortical interstitial 
solute was associated with motor and cognitive neurological defi-
cits (26). While CSF-ISF exchange within the glymphatic pathway 
is improved by increased cerebral penetrating arterial pulsatility 
(27), the sleep state (20), and a lateral head position during sleep 
(28), none of these regulatory factors have yet been demonstrat-
ed to improve waste clearance in any of the above disease states. 
Consequently, a critical area of future glymphatic research is iden-
tification of novel mechanisms to control flow through this path-
way with the goal of modifying diseases characterized by toxic 
extracellular solute accumulation.
Is Aβ cleared along the periarterial space?
Cerebral amyloid angiopathy is a disease process characterized by 
accumulation of soluble Aβ within the walls of cerebral arteries, 
ultimately weakening the integrity of these vessels and leading to 
lobar hemorrhage (29). Based on this observation, Weller, Cara-
re, and colleagues hypothesized that, contrary to the glymphat-
ic model, interstitial waste clears from brain within an arterial 
intramural pathway (30). Using ex vivo fluorescence and electron 
microscopy, this group demonstrated that tracer molecules inject-
ed directly into brain appear within the basement membranes of 
cerebral capillaries and smooth muscle cells of the arterial tunica 
media (30). These tracer imaging experiments were qualitative, 
making it difficult to determine whether periarterial efflux was a 
major phenomenon. Additionally, it is unknown whether this flow 
pattern is specific to the striatum, where all tracer injections were 
performed, or rather more broadly characteristic of the entirety 
Deleting these water channels reduced CSF tracer movement 
from the periarterial spaces into the interstitium, and resulted in 
markedly impaired clearance of extracellular solutes, including 
amyloid-β (Aβ) (15). Taken collectively, this suggests that CSF 
flows into brain within periarterial spaces, ISF and solute clear 
via perivenous spaces, and AQP4 decreases resistance to CSF-
ISF exchange between parenchymal perivascular and interstitial 
spaces. As a result of this dependence on astrocytic AQP4 chan-
nels and the “lymphatic” function it subserves for brain, Iliff and 
colleagues termed this pathway the glial-associated lymphatic 
system, or glymphatic system (ref. 15 and Figure 1).
Glymphatic perfusion of the CNS serves multiple purposes 
in neurophysiology. The glymphatic pathway is important for the 
brain-wide delivery of nutrients, specifically glucose (17), the cir-
culation and distribution of apolipoprotein E isoforms produced 
by the choroid plexus (18), and even astrocytic paracrine signal-
ing with lipid molecules (19); however, its most fundamental 
role is the “lymphatic” function it serves in clearing extracellular 
metabolites and waste products from the parenchyma into the 
CSF. Reductions in brain efflux of radiolabeled mannitol and Aβ 
were observed in AQP4-deficient mice with slowed glymphat-
ic flow (15). Further, interstitial lactate that accumulates in the 
course of normal daily brain activity was shown to be cleared by 
the glymphatic system in the transition from wakefulness to sleep 
(20). Suppression of glymphatic pathway function with AQP4 
Figure 1. Circulation of CSF, ISF, and brain solute through the glymphat-
ic pathway. (A) CSF within the subarachnoid and cisternal spaces flows 
into brain specifically via periarterial spaces and then exchanges with ISF 
facilitated by aquaporin-4 (AQP4) water channels that are positioned within 
perivascular astrocyte end-foot processes. The bulk movement of CSF 
into brain drives the convective flow of ISF and interstitial solute through 
the extracellular space to ultimately collect within perivenous spaces. (B) 
Perivenous fluid and solute then drain from brain predominantly alongside 
large-caliber ventral veins. Once within the subarachnoid CSF, solutes such 
as amyloid-β can exit the cranium via arachnoid granulations or meningeal 
lymphatic vessels or along cranial and spinal nerves; however, a proportion is 
also capable of recirculating into brain via periarterial spaces. Periarterial sol-
ute may seed and accumulate within the basement membranes of smooth 
muscle cells, precipitating conditions such as cerebral amyloid angiopathy.
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port of solutes is mediated by diffusion (36–38). These reports are, 
however, contradicted by the classical studies from Cserr’s group, 
which observed that transport velocity of intraparenchymal tracers 
was independent of their molecular size and therefore concluded 
that solute transport is mediated by convective flow (10–12). A 
more inclusive and validated model must therefore be established 
under healthy and pathological conditions to further demonstrate 
the contribution of periarterial and perivenous drainage.
Anatomy of lymphatic vessels in the dura mater
The lymphatic vascular network is a unique blind-ended unidi-
rectional absorptive and transport system that penetrates most 
human tissues. It consists of draining lymphatic vessels, lymph 
nodes, and associated lymphatic organs. In mammalian embryos, 
the lymphatic organ system develops when the cardiovascular sys-
tem has already started to function (39, 40). Unlike blood vessels, 
the lymphatic vessels do not form a closed circulatory network. In 
peripheral organs, lymphatic drainage contributes considerably to 
tissue fluid homeostasis and immune surveillance by facilitating 
the clearance of excess interstitial tissue fluid, macromolecules, 
and immune cells from the interstitium back into blood circula-
tion. In the lymphatic network, fluid, cells, and macromolecules 
are first absorbed by blind-ended lymphatic capillaries (the initial 
lymphatic vessels), and the flow proceeds via precollector and col-
lector lymphatic vessels and lymph nodes, ending in the thoracic 
duct and the right lymphatic trunk, which deliver lymph into sub-
clavian veins in the neck region (2).
The meninges that envelop the brain and spinal cord partici-
pate in forming the various fluid compartments of the CNS. They 
are composed of three layers (“maters”), termed pia, arachnoid, 
and dura. The innermost pial layer lines and invests the brain 
parenchyma, whereas dura is adherent to the skull. Although a 
few isolated lymphatic vessels were previously reported around 
the cranial nerves and dural blood vessels (41–43), the CNS and its 
meningeal linings were long believed to be devoid of a lymphatic 
vascular system, which has posed long-standing questions about 
brain waste clearance, ISF/CSF outflow mechanisms, and immune 
surveillance (44). Recent work has described the extensive menin-
geal lymphatic vessel network that serves macromolecular clear-
ance and immune cell trafficking functions in the brain (45, 46). 
Characterization of the entire network of vessels in the dura mater 
overlying the skull bones was possible using lymphatic EC-specific 
fluorescent reporters and immunofluorescent staining. Lymphatic 
vessels located alongside the arteries, major venous sinuses, and 
cranial nerves appear to provide a pathway of drainage out from 
the cranium along these anatomical structures via the various 
foramina at the base of the skull (45, 46). Furthermore, lymphat-
ic vessels under the olfactory bulb crossed the cribriform plate, 
where olfactory nerves travel through bone into the nasal mucosa. 
Interestingly, meningeal vessels were thus found in similar periar-
terial and perineural locations where ISF and CSF flow was previ-
ously observed (47–50). Compared with the superior portions of 
the skull, the dural lymphatic network in the basal parts was more 
extensive and contained valves whose function was not obvious, 
as fluid outflow from the head is ensured by gravity even without 
valves, which are needed in other parts of the body to prevent 
backflow in collecting lymphatic vessels.
of the cerebrum. Further, it is possible that there was retrograde 
flow of tracer along the cannula track into the subarachnoid CSF, 
suggesting that periarterial tracer was due to glymphatic CSF 
influx rather than ISF efflux. Finally, as shown in a recent study 
by Bedussi and colleagues, the appearance of tracer in a periarte-
rial distribution may result from pressure injection of tracer into 
brain tissue immediately adjacent to an artery, rather than occur-
ring as a consequence of true ISF bulk flow (31). Based on these 
findings, however, it was postulated that once within the arterial 
wall, parenchymal solutes travel in a direction opposite to blood 
flow toward larger and more proximal vessels until they ultimate-
ly reach the internal cerebral artery (ICA), where solute can be 
drained by deep cervical lymph nodes (dcLNs) (30, 32, 33). While 
Aβ has been detected within the walls of intracerebral arteries, 
including those of young individuals (34), intramural Aβ has never 
been identified within the ICA immediately outside the skull (32), 
challenging the notion that solutes use periarterial pathways to 
exit the cranium, and instead suggesting that arterial walls may be 
vulnerable to metabolite accumulation.
As the above-discussed experiments were all conducted ex 
vivo lacking temporal resolution, it is difficult to conclude that 
periarterial spaces are the most immediate site of parenchymal 
solute drainage. Rather, it is equally possible that waste accu-
mulation around arteries represents a recirculation event, where 
interstitial metabolites, including Aβ, first clear via glymphatic 
perivenous spaces to the subarachnoid CSF compartment. Subse-
quently, Aβ reenters brain within periarterial spaces, and begins 
depositing after coming in contact with the adhesive smooth 
muscle and capillary basement membranes. Like that seen in oth-
er small vessel diseases, such as CADASIL (35), altered protein 
expression in periarterial spaces may increase molecular affinity 
for Aβ and thereby precipitate pathological accumulation.
Finally, to further bolster the concept of intramural, peri-
arterial clearance, one study suggests that, as a result of close 
compaction of astrocyte end-foot processes, the glial basement 
membrane, pial membrane, and outer smooth muscle basement 
membrane, perivascular spaces do not exist within either the 
murine or the human cortex (33). However, data from this same 
group seem to refute this contention, demonstrating the presence 
of fluorescent microspheres ranging from 20 nm to 100 μm in 
size within perivascular distributions (30). Additionally, Iliff and 
colleagues identified CSF-based tracer within both the endothe-
lial basement membrane and the perivascular space between the 
arterial smooth muscle and the astrocyte end-foot of the glial lim-
iting membrane (15). More recent studies propose a model of bidi-
rectional fluid and solute movement within periarterial spaces — 
CSF influx within the outer glymphatic pathway and ISF efflux via 
the inner intramural pathway (32). Computational modeling stud-
ies support this idea, suggesting that the orientation of basement 
membrane structures and reflection of the cardiac pulse wave at 
arterial branch points may play a role in promoting this reverse 
transport process (36, 37), but at present there are no empirical 
data to support either mechanism. It is here important to note that 
no tracers have been observed in the periarterial space moving 
against the direction of blood flow or the pulsatility of the vascular 
wall in 2-photon live-imaging experiments. Similarly, the compu-
tational modeling studies have suggested that glymphatic trans-
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(50). After the identification of arachnoid granulations over three 
centuries ago, various independent studies established their role 
in CSF outflow into the dural venous sinuses (51–54). Numerous 
groups reported the lymphatic clearance route after observing the 
transfer of macromolecules and tracers from brain parenchyma or 
CSF space into the extracranial lymphatic vasculature in various 
animal species (47, 50, 55–59). Until recently, clearance from the 
intracranial side was thought to occur via perineural sheaths of 
cranial and spinal nerves (58, 60, 61). Observations of CSF trac-
Dural lymphatic vessels in ISF and CSF clearance
According to previous studies, several different pathways contrib-
ute to circulation and extracranial clearance of CNS extracellular 
fluid compartments containing ISF and CSF. The perivascular 
exchange of fluid and solutes between ISF and CSF has been dis-
cussed in the previous sections. CSF produced by choroid plexuses 
in the brain ventricles and circulated into cranial and spinal SAS is 
considered to be drained via a dual outflow system consisting of 
the arachnoid granulations and the extracranial lymphatic system 
Figure 2. Glymphatic and lymphatic drainage pathways from the CNS to the cervical lymph nodes. (A) Schematic illustration of the meningeal lymphat-
ic vessel system in mouse cranium. The dural lymphatic vessels align with dural blood vessels and cranial nerves and exit the cranium via the foramina 
together with the venous sinuses, arteries, and cranial nerves. Some lymphatic vessels are also found traversing the cribriform plate with the olfactory 
nerves. Tracers injected into either brain parenchyma or SAS drain via the dural lymphatic vessels into dcLNs located next to the jugular vein. (B) Close-up 
view of ISF and CSF circulation. The perivascular glymphatic drainage system transports CSF and solutes into the brain via a periarterial pathway, whereas 
ISF and solutes exit the brain via the perivenous glymphatic pathway. CSF can enter the venous system via arachnoid granulations, and CSF macro-
molecules and immune cells are transported mainly along the dural lymphatic vessels into the lymph nodes and extracranial systemic circulation. (C) 
Out-of-CNS drainage routes for antigens and antigen-presenting cells (APCs). Antigens and APCs are proposed to leave the CNS via either (i) lymphatics of 
the cribriform plate, reaching the nasal mucosa lymphatic vasculature (particularly, dendritic cells may migrate along the rostral migratory stream [RMS] 
to enter the lymphatics via the olfactory bulb’s SAS); or (ii) the glymphatic pathway (as demonstrated for antigens), reaching the SAS and entering the 
meningeal lymphatic vasculature via SAS and trafficking to the dcLNs. APCs within the meningeal spaces may also leave through meningeal lymphatic 
vessels into the dcLNs. Each pathway’s contribution to cell and antigen drainage has yet to be determined.
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Cserr et al. estimated that between 14% and 47% of albumin 
tracer injected into the brain or CSF passes through the extra-
cranial lymphatic system (59). However, the exact proportion of 
clearance along the meningeal lymphatics adjacent to blood ves-
sels and spinal and cranial nerves is not yet known and may vary 
between species as well as in response to the functional dynamics 
of other outflow routes (45, 46). Arachnoid villi mature during late 
fetal and early postnatal periods and start to degenerate along with 
the choroid plexus in senescence (67–70), suggesting that adap-
tive changes in CSF clearance also occur via the different routes. 
Moreover, mice born without meningeal lymphatic vessels did not 
show any quantitative changes in brain interstitial fluid pressure or 
water content, further suggesting effective compensatory or adap-
tive mechanisms in the unchallenged state (46).
CNS compartments and their immune 
connection
The term “immune privilege” was coined by Peter Medawar to 
describe a tissue or organ in which the introduction of foreign anti-
gen does not elicit an immune response. Experiments conduct-
ed by Medawar and colleagues in the late 1940s introduced the 
notion that the brain parenchyma is an immune-privileged site. 
Unlike similar grafts in the periphery, skin allografts implanted 
into the brain parenchyma elicit a delayed graft rejection (71). Less 
well known — though not less interesting — is that if an immune 
response toward allograft antigens has already been established in 
the periphery prior to grafting into brain parenchyma, the brain’s 
immune response to the allograft will be similar to the peripheral 
organs’ response (71). That finding suggests that although anti-
gens within the brain do not prime an immune response, they can 
maintain and potentiate it. CNS immune privilege was attribut-
ed, in part, to a lack of lymphatic drainage from the CNS, with 
consequent failure to allow antigen presentation on professional 
antigen-presenting cells (such as dendritic cells). Interestingly, a 
regular immune response could be elicited when the allograft was 
implanted close to the ventricles or within the SAS, suggesting that 
compared with other brain areas, the meningeal spaces are more 
in touch with peripheral immunity (72, 73).
The brain’s parenchymal and CSF/meningeal compartments 
possess different properties that confer on each a unique immune 
status. Under physiological conditions, numerous immune cells 
carry out CNS surveillance and occupy the CSF/meningeal com-
partment (45, 74–76). Meningeal ECs lack astrocytic end-feet 
and also differ in other ways from brain ECs. As a result, the 
blood-meningeal barrier is more permissive than the blood-brain 
barrier to entry of immune cells and allows them to circulate with-
in the meninges under homeostatic conditions (77). The ability 
of such meningeal immune cells to penetrate the brain parenchy-
ma under pathological conditions (assuming that this does occur 
physiologically) is still not fully understood (78).
Tracing studies have revealed marked differences between 
the draining properties of the meningeal and parenchymal com-
partments (Figure 2C). Macromolecules and tracers injected into 
the SAS rapidly reach the cervical lymph nodes, suggesting that 
CSF constituents can easily drain outside the CNS and thus poten-
tially elicit an immune response. The different routes potentially 
implicated in such drainage were described earlier (see “Dural 
ers entering the lymphatic vessels of nasal mucous membranes 
through the cribriform plate suggested that the most important 
CSF outflow mechanism into extracranial lymphatic system would 
be via perineural SAS enveloping the olfactory nerve sheaths (47, 
61–63). Besides cranial perineural flow, tracer studies also suggest-
ed that CSF from the spinal SAS would terminate in the regional 
lymphatics outside of the spinal canal via perineural pathways 
(64, 65). The latest addition into the ISF/CSF outflow system is the 
recently discovered meningeal lymphatic vasculature along the 
cranial nerves, arteries, and veins that traverse together through 
the cranial foramina and serve as a direct, continuous connection 
between the intracranial space and extracranial lymphatic vascu-
lature (refs. 45, 46, and Figure 2, A and B).
Fluorescent tracer and macromolecule injections into dif-
ferent CNS compartments have elucidated the functionality of 
dural lymphatic vessels. Tracers injected into brain parenchyma 
and ventricles were observed along the meningeal lymphatic 
vessels and drained primarily into the dcLNs, but not into non–
brain-draining lymph nodes (45, 46). In a mouse model devoid 
of meningeal lymphatic vasculature, cerebral macromolecule 
clearance was attenuated and drainage into dcLNs was almost 
completely abrogated, suggesting direct clearance of macromol-
ecules via meningeal lymphatic vessels into extracranial lym-
phatic tissue (46). Furthermore, surgical ligation of the lymphat-
ic vessels emanating from dcLNs prevented tracer accumulation 
into the lymph node, led to increased meningeal T cell numbers, 
and enhanced tracer filling of the dural lymphatic network in the 
basal parts of the skull (45, 46). These observations further indi-
cated a role for the dural lymphatic vessels in transporting intra-
cranial cells, macromolecules, and ISF/CSF to the extracranial 
lymphatic system.
The location of the lymphatic vessels close to the SAS suggests 
that they absorb CSF from the arachnoid mater; however, the 
direct mechanism of fluid and macromolecular uptake into dural 
lymphatics is still unknown. It has been speculated that some of 
the CSF transported across the arachnoid barrier layer collects 
in the dural border interstitium and into “unlined channels” for 
further transportation or absorption into the endothelial-lined 
parasagittal plexus (50). Intraparenchymally injected tracers 
translocated to the dcLNs were also observed in the glymphatic 
space, suggesting a connection between the glymphatic and men-
ingeal lymphatic systems (46). Considering that the glymphatic 
exit pathway from the brain interstitium is along veins (see “The 
glymphatic system: anatomy and function in health and disease” 
above) and that the dural lymphatics in many locations flank com-
municating veins, some glymphatics may be closely associated 
with absorptive lymphatic vessels, whose intercellular junctions 
are compatible with fluid entry.
Blockade of different outflow routes has demonstrated the 
importance of the lymphatic outflow route in maintaining nor-
mal intracranial fluid homeostasis. Surgical blockade of the 
perineural cribriform pathway was previously reported to cause 
rapid and sustained increase in intracranial pressure (66). More-
over, in dogs, acute interruption of lymphatic outflow by ligation 
of the cervical lymphatic vessels leading to cervical lymph nodes 
caused profound intracranial consequences, including a rise in 
intracranial pressure (47).
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lymphatic vessels in ISF and CSF clearance” above). Similarly 
to tracers, injection of immune cells into the SAS results in their 
accumulation in the CNS-draining but not in non–brain-draining 
lymph nodes (79).
Tracers injected into the brain parenchyma itself also drain 
into the cervical lymph nodes (26, 59). As discussed above, this 
connection is primarily due to the glymphatic system that connects 
ISF and CSF (15). In both rodent and primate models of multiple 
sclerosis, for example, brain antigens were increased in the cervi-
cal lymph nodes (80, 81). After stroke, brain injury, or oligoden-
drocyte death induced by diphtheria toxin, myelin antigens have 
similarly been found to accumulate in the cervical lymph nodes 
(82–84). Drainage of brain antigens has been observed in animal 
models not only of autoimmune diseases but also of Alzheimer’s 
disease. Aβ, for example, was detected in the cervical lymph nodes 
in murine models of Alzheimer’s disease (85).
Injection of immune cells into the brain parenchyma has yielded 
controversial findings. While some studies have followed injections 
of T cells, monocytes, or dendritic cells from the brain parenchyma 
to their ultimate drainage into the cervical lymph nodes, others have 
failed to document any such drainage after intracerebral injection (79, 
86–89). Furthermore, the perivascular pathway is likely incapable of 
allowing the passage of immune cells (48), raising the possibility that 
at least some of the observed drainage might be due to postinjection 
leakage into the CSF/meningeal compartment. In yet other studies, 
the cribriform plate was proposed as the route by which immune 
cells exit the CNS and reach the nasal lymphatics (87, 88). Clearly, 
the notion that T cells or dendritic cells within the brain parenchyma 
have migratory potential to leave the parenchyma remains a matter 
of debate. Not only are microglia nonmigratory cells, but studies have 
also suggested that the brain parenchymal environment promotes 
the death of T cells and dendritic cells rather than recirculation (90, 
91). Thus, recirculation of infiltrating immune cells from the brain 
parenchyma might not occur under physiological (or even patho-
logical) conditions. Recent work suggests that endogenous CD11c+ 
cells might recirculate from the CNS under neuroinflammatory con-
ditions, but the exact provenance of such cells (meningeal or brain 
compartment) remains uncertain (92).
All in all, accumulating evidence indicates that the brain’s 
parenchymal and CSF/meningeal compartments each possess 
distinctive drainage characteristics that endow them with unique 
immune properties.
Communication between the CNS compartments
While the brain and the meninges have distinctive drainage prop-
erties, they are not isolated from one another and can indeed com-
municate. Intermixing between the ISF and the CSF (as described 
in previous sections) reflects their direct contact. CSF and its con-
stituents can act directly on brain function. Notably, vitamin C and 
folate diffuse into the brain through the CSF (93, 94). Many other 
ions and proteins are transported through the choroid plexus epi-
thelium and diffuse from the CSF into the brain, where they affect 
neuronal function (94). More recently, the immune compartment 
in the meninges was implicated in neuronal function (75). Nota-
bly, IL-4 and IL-13 production by meningeal T cells appears to con-
tribute to the maintenance of cognitive function in mice (74, 95). 
Furthermore, production of IFN-γ in the SAS directly regulates 
social behavior in mice (96).
Taken together, the evidence indicates that the brain and men-
ingeal compartments are not isolated from one another and that 
macromolecules and antigens from the brain parenchyma can 
access the CSF and then drain into the cervical lymph nodes via the 
meningeal lymphatic vasculatures (and possibly additional routes).
Generation of immune responses and immune 
privilege
As outlined above, the available evidence suggests that antigens 
from the CNS can access the cervical lymph nodes, and from there 
potentially induce an immune response. It was recently demon-
strated that induction of massive death of oligodendrocytes leads 
to the generation of autoreactive T cells that can indeed induce 
multiple sclerosis–like symptoms in mice (83). Furthermore, 
expression of a foreign antigen on oligodendrocytes induces T cell 
response in the draining lymph nodes (97). These findings demon-
strate that brain antigens can drain into cervical lymph nodes and 
generate an immune response there. Such a response might devel-
Figure 3. Potential modulation of T cell acti-
vation by lymphatic ECs. Lymphatic ECs (LECs) 
(primarily within the lymph nodes) can modulate 
T cell activation directly, either by producing 
modulatory molecules (NO, IDO, TGF-β) or by 
expressing MHC and costimulatory molecules like 
PDL1. Alternatively, the regulation can also be 
indirect by inducing maturation of dendritic cells 
(DCs) via ICAM-1 expression. Moreover, soluble 
molecules draining from the CSF to the dcLNs are 
taken up by subcapsular APCs (DCs and macro-
phages), resulting in modulation of B and T cell 
activation in the dcLNs. This function of menin-
geal lymphatic vessels in regulation of meningeal 
T cell tolerance has not yet been explored. IDO, 
Indoleamine 2,3-dioxygenase; PD1, programmed 
death 1; PDL1, Programmed death ligand 1.
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op more slowly, require a larger amount of antigen release, or need 
a secondary signal (like danger- or pathogen-associated molecular 
patterns [DAMPs or PAMPs]) to be drained alongside the antigens 
to be generated. These limitations may explain why allografts in 
the brain parenchyma survive longer.
Another scenario envisages the possible existence of mech-
anisms within the CNS to ensure that immune responses to 
CNS-draining antigens are limited, or at least tightly regulated, via 
established peripheral tolerance. It could be argued that the unique 
nature of lymphatic drainage from the CNS is indeed what drives 
the phenomenon of immune privilege. Lymphatic ECs are report-
edly able to shape the immune response (98–100). Although most 
evidence comes from lymph node–resident lymphatic ECs, menin-
geal lymphatic ECs might have unique properties that induce and 
control immune tolerance; if so, the specific mechanism through 
which tolerance to CNS antigens is established might implicate the 
meningeal lymphatic vessels. The existence of these vessels, there-
fore, does not question the immune privilege but rather mechanis-
tically underlies it (refs. 101, 102, and Figure 3).
In an alternative scenario, it is possible that cervical lymph 
nodes possess unique properties that modulate the immune 
response to CNS-drained antigens. As recently demonstrated, 
strategic placement of macrophages and dendritic cells in lymph 
node capsules positions them as major players in orchestrating 
the proper activation of T and B cells in the lymph nodes (103). It 
might be hypothesized that CNS-draining lymph nodes are capa-
ble of tolerizing or tuning down an immune response.
Accumulating evidence over decades of research has shown 
that drainage from the brain parenchyma and its surroundings 
does indeed occur under both normal and pathological condi-
tions, and therefore cannot account for the status of immune 
privilege as originally defined. It remains for in-depth studies to 
investigate and eventually understand how CNS antigens induce 
their unique immune responses. Among the first questions to be 
addressed are those concerning the contribution of the different 
drainage routes to CNS function under healthy and diseased con-
ditions. We also suggest that the cervical lymph nodes should be 
examined and compared with those of peripheral systems as a 
critical step toward deciphering the specific mechanisms of CNS 
immune responses.
Glymphatic-lymphatic connection: final remarks 
and take-home messages
Finally, it is important to summarize several facts about the men-
ingeal lymphatic and glymphatic systems, to emphasize their con-
nection, and to highlight current gaps of knowledge and where the 
research in this field should be headed.
First, although a potential lymphatic connection between the 
CNS and periphery has been previously proposed, and although 
some works indicated a possible presence of lymphatic vessels 
in the meninges (47, 55–59, 61) and even in the CNS parenchy-
ma (104), recent publications using state-of-the-art microscopy 
have molecularly characterized and assessed the function of the 
meningeal lymphatic vessels in greater depth (45, 46). The pres-
ence of these vessels in different species, their precise location 
within the meningeal layers, and their accessibility by the CSF 
need further investigation.
Second, the discovery of meningeal lymphatic vessels does 
not question the mere presence of CNS immune privilege (or what 
would be more precisely termed “immune uniqueness”). This dis-
covery certainly challenges the dogma that CNS immune privilege 
is in part due to the absence of CNS lymphatic drainage. Based on 
lessons mostly learned from tumor immunology (99, 100), men-
ingeal lymphatic vessels may, in fact, provide a plausible mecha-
nistic explanation for how CNS tolerance is established. Under-
standing how meningeal lymphatic vessels contribute to a unique 
immune status toward CNS-derived antigens demands intensive 
further investigation.
Third, multiple routes are proposed to allow the circulation of 
immune cells from the CNS to the periphery (meningeal lymphat-
ics, refs. 45, 101; cribriform plate, refs. 87, 88; and rostral migra-
tory stream, ref. 86). In-depth analysis of the contribution and 
functions of the different paths under both normal and patholog-
ical conditions is necessary to fully understand how the immune 
system senses the CNS and how each route might differential-
ly contribute to generating and maintaining immune responses 
toward the CNS.
Fourth, the glymphatic system has been demonstrated to be 
responsible for movement of the CSF through the brain parenchy-
ma (15). CSF moves into brain specifically within periarterial spac-
es and interchanges with ISF owing to the presence of AQP4 water 
channels in perivascular astrocyte end-foot processes. ISF then 
drains from brain within perivenous channels, again with AQP4 
decreasing the resistance to fluid flow (15). Bulk flow of CSF and 
ISF within this pathway, driven by cerebral arterial pulsatility and 
sleep (20, 27), has been shown to be critical for the elimination of 
interstitial waste products such as Aβ (15). This is the only plau-
sible system that would explain the abundant presence of CNS- 
derived molecules within the CSF. Previous works arguing that 
ISF and interstitial solutes are drained via a periarterial intramu-
ral pathway (30, 32) are misleading because they are performed ex 
vivo. Therefore, they provide little dynamic information regarding 
ISF flows, making it difficult to conclude that periarterial spaces 
are the most proximal site of ISF drainage. It is likely that periar-
terial solute accumulation is the result of solute recirculation into 
brain from the CSF compartment. Additionally, as these studies 
often lack quantitation, it is unknown whether periarterial clear-
ance is a representative or sporadic phenomenon.
It should be noted, however, that other clearance systems 
have been implicated in the removal of protein, notably Aβ, from 
the brain parenchyma. Indeed, studies report transvascular clear-
ance of Aβ primarily via LDL receptor–related protein 1 but also 
its removal by pericytes and myeloid cells (105–111). All these sys-
tems, including glymphatic and lymphatic drainage, must work in 
symbiosis to ensure the proper removal of protein. Thus, addition-
al studies must address the physiological and pathophysiological 
interactions of the brain’s clearance systems.
Fifth, the connection between the glymphatic system and 
meningeal lymphatic drainage has been demonstrated (46). This 
continuous flow of CSF that perfuses the brain parenchyma and 
is drained to cervical lymph nodes provides a plausible route to 
study CNS-immune connection (101, 102). Future studies should 
strengthen the functional connection between the glymphatic 
flow and the meningeal lymphatic drainage. Moreover, hypo- or 
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hyperfunction of this connection may underlie neuroinflammato-
ry and neurodegenerative disorders (especially those associated 
with protein accumulation). Function and dysfunction of menin-
geal lymphatic vessels and their connection to the glymphatic sys-
tem should be addressed by future works.
Identification of meningeal lymphatic vessels and of the 
glymphatic system has reinvigorated the study of CNS immune 
privilege, its drainage, and fluid flow/perfusion through the CNS 
parenchyma. Further works should aim at better understanding 
of the connection between the two systems and their malfunction 
in neurological conditions. This complex yet mechanistically solid 
system could provide new therapeutic targets for neurological dis-
orders associated with immune malfunction and/or protein aggre-
gation, potentially leading to new therapies.
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